openPR Logo
Press release

Renal Denervation Devices Market - Global Industry Analysis, Size, Share, Growth, and Forecast 2012 - 2021

01-05-2017 03:25 PM CET | Health & Medicine

Press release from: Transparency Market Research

Renal Denervation Devices Market - Global Industry Analysis,

According to a recent market research report released by Transparency Market Research, the global renal denervation devices market is estimated to take a leap at a CAGR of 41.2% during the period between 2012 and 2021. The report, titled “Renal Denervation Devices Market - Global Industry Analysis, Size, Share, Growth, and Forecast 2012 - 2021”, projects the global renal denervation devices market to be worth US$1.9 bn in 2021. The overall market was worth US$88.5 mn in 2012.

Growing prevalence of hypertension among urban population has significantly contributed to the growth of the global renal denervation devices (RDN) market. Renal sympathetic nerves are directly affected in hypertension. The report cites the increasing cases of treatment resistant hypertension and uncontrolled hypertension as the key factors driving the global renal denervation devices market. Short duration and permanent effect of renal denervation procedure will increase adoption of RDN devices. Further, rapid development of RDN devices and growing geriatric population worldwide will augment the growth of the global renal denervation devices market.

However, the report mentions that the shortage of clinical evidence is restraining the expansion of the global renal denervation devices market. Lower awareness of RDN devices as compared to drug-based therapy along with unstable reimbursement regulations will hinder the growth of the overall market during the forecast horizon. The report points out that the renal denervation devices market has a huge opportunity to grow in the emerging economies.

On the basis of technology, the global renal denervation devices market has been segmented into ultrasound- based renal denervation systems, renal sympathetic denervation procedure, radiofrequency-based renal denervation systems, and micro-infusion catheter-based renal denervation systems. In 2012, radiofrequency-based RDN devices accounted for the largest share of the market. Due to benefits such as time-efficiency and safety, radiofrequency-based RDN devices will continue to dominate the global renal denervation devices market.

On the basis of product, the report focuses on ReCor Medical's Paradise, Boston Scientific's (Vessix Vascular) V2, Medtronic's Symplicity, St. Jude's EnlighHTN, and Covidien's OneShot. In 2012, Medtronic’s Symplicity accounted for around 85.5% market share. However, during the forecast period, this product is expected to face stiff competition from other emerging products in the market.global-renal-denervation-devices-market-2012-2021

The report studies the global renal denervation devices market across four key regions: Europe, North America, Asia Pacific, and Rest of the World. Europe leads the global renal denervation market owing to a large number of research and development activities and device approvals. The region held 80% of the market in 2012 and is estimated to dominate the overall market during the forecast horizon. Asia Pacific is expected to follow Europe as the second largest market for renal denervation devices.

The report profiles some of the key players in the global renal denervation devices market such as Medtronic Inc., Kona Medical, Boston Scientific Corporation, St. Jude Medical, Covidien PLC, CardioSonic, and Mercator Medsystems.

Download Free exclusive Sample of this report:

http://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=400

The research study has been segmented as below:

Renal Denervation Devices Market, by Technology

Radiofrequency
Ultrasound
Micro-infusion
Others
Renal Denervation Devices Market, by Product

Symplicity
EnlighHTN
OneShot
Paradise
V2
Renal Denervation Devices Market, by Geography

North America
Europe
Asia Pacific
Rest of the World
Browse : Our new press releases http://www.transparencymarketresearch.com/pressrelease/global-renal-denervation-devices-market.htm

About Us

Transparency Market Research (TMR) is a global market intelligence company providing business information reports and services. The company’s exclusive blend of quantitative forecasting and trend analysis provides forward-looking insight for thousands of decision makers. TMR’s experienced team of analysts, researchers, and consultants use proprietary data sources and various tools and techniques to gather and analyze information.

TMR’s data repository is continuously updated and revised by a team of research experts so that it always reflects the latest trends and information. With extensive research and analysis capabilities, Transparency Market Research employs rigorous primary and secondary research techniques to develop distinctive data sets and research material for business reports.

Contact

Mr.Sudip S
90 State Street, Suite 700
Albany, NY 12207
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453
Email: sales@transparencymarketresearch.com
Website: http://www.transparencymarketresearch.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Renal Denervation Devices Market - Global Industry Analysis, Size, Share, Growth, and Forecast 2012 - 2021 here

News-ID: 406515 • Views:

More Releases from Transparency Market Research

Medium Voltage Fuse Market Outlook 2031: Global Market to Reach US$ 1.8 Billion by 2031, Driven by Renewable Energy Expansion and Infrastructure Electrification
Medium Voltage Fuse Market Outlook 2031: Global Market to Reach US$ 1.8 Billion …
The global medium voltage fuse market is steadily transitioning from a traditional grid-protection niche to a strategic enabler of modern power systems. Rising investments in renewable energy integration, large-scale electrification programs, and infrastructure upgrades are reshaping demand patterns worldwide. Medium voltage fuses-typically rated between 1 kV and 35 kV-are no longer viewed as passive safety components; instead, they are increasingly recognized as critical assets for grid stability, asset protection, and
Lamination Films Market Outlook 2032: Global Industry Size to Surpass US$ 12.21 Billion by 2032, Driven by Food Safety Regulations, E-Commerce Growth, and Advanced Multilayer Packaging Solutions
Lamination Films Market Outlook 2032: Global Industry Size to Surpass US$ 12.21 …
The global lamination films market was valued at US$ 8,123.4 million in 2023 and is forecast to reach US$ 8,514.1 million in 2024. Over the forecast period from 2024 to 2032, the market is projected to expand at a compound annual growth rate (CAGR) of 4.6%, ultimately exceeding US$ 12,213.1 million by 2032. This steady growth trajectory reflects the indispensable role of lamination films in modern packaging ecosystems across food,
Global Curcumin Market Outlook 2031: Natural Antioxidant Demand, Regional Growth Trends, and Investment Opportunities Driving a US$ 608.2 Million Market
Global Curcumin Market Outlook 2031: Natural Antioxidant Demand, Regional Growth …
The global curcumin market is entering a structurally strong growth phase, underpinned by rising consumer preference for natural, plant-based ingredients and increasing clinical validation of curcumin's antioxidant and anti-inflammatory properties. As consumers shift away from synthetic additives and chemical-based therapeutics, curcumin is emerging as a high-value bioactive ingredient across , functional foods, cosmetics, and pharmaceuticals. Premiumization trends in organic products, combined with regulatory validation from food safety authorities, are expected
Hemoglobin A1c Testing Devices Market to be Worth More Than USD 3.3 Bn by 2034 - By Technology / By Modality | U.S. • Germany • China • India
Hemoglobin A1c Testing Devices Market to be Worth More Than USD 3.3 Bn by 2034 - …
The global Hemoglobin A1c (HbA1c) Testing Devices Market was valued at US$ 1.4 Bn in 2023 and is projected to expand at a CAGR of 7.7% from 2024 to 2034, reaching more than US$ 3.3 Bn by the end of 2034. The market growth is primarily attributed to the increasing global burden of diabetes, growing awareness about disease management, and technological advancements in diagnostic devices. Get a concise overview of key

All 5 Releases


More Releases for Renal

Advancements in Renal Dialysis Equipment Trend: A Crucial Influence on the Renal …
What market dynamics are playing a key role in accelerating the growth of the renal dialysis equipment market? The escalating incidence of chronic kidney disease is projected to boost the expansion of the renal dialysis equipment market. Chronic kidney disease, a term that describes the slow and progressive decline of kidney function, can ultimately result in kidney failure and other severe health conditions. This disease is linked with several risk factors
Renal Osteodystrophy Market: An In-Depth Analysis
The Renal Osteodystrophy Market was valued at approximately USD 2.4 billion in 2023 and is projected to reach around USD 7.1 billion by 2032, exhibiting a compound annual growth rate (CAGR) of 12.5% from 2024 to 2032. Renal Osteodystrophy Market Overview The Renal Osteodystrophy Market is experiencing significant growth, driven by the increasing prevalence of chronic kidney disease (CKD) and the associated bone disorders. Advancements in diagnostic techniques have enhanced early
Shaping the Renal Dialysis Equipment Market in 2025: Advancements in Renal Dialy …
How Big Is the Renal Dialysis Equipment Market Expected to Be, and What Will Its Growth Rate Be? In recent years, the renal dialysis equipment market has seen robust growth. It's projected to increase from $19.52 billion in 2024 to $20.92 billion in 2025, demonstrating a compound annual growth rate (CAGR) of 7.2%. Factors contributing to growth in the historic period include comprehensive training and support programs, substantial research and development
Transforming the Veterinary Renal Disease Market in 2025: Increasing Pet Ownersh …
"What Is the Expected Size and Growth Rate of the Veterinary Renal Disease Market? The market size for veterinary kidney diseases has seen profound growth recently. It is set to expand from $15.5 billion in 2024 to $16.63 billion in 2025, with a compound annual growth rate (CAGR) of 7.3%. Several factors contributed to this growth during the historical period, including heightened initiatives to increase disease awareness, a shift in
Renal Cancer Pipeline Outlook Report 2024
DelveInsight's, "Renal Cancer Pipeline Insight 2024" report provides comprehensive insights about 75+ Renal Cancer companies and 80+ pipeline drugs in the Renal Cancer pipeline landscape. It covers the Renal Cancer pipeline drug profiles, including clinical and nonclinical stage products. It also covers the Renal Cancer pipeline therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space. Key Takeaways
Renal Biomarker Market to register a CAGR of 7.0% by 2026: Rising Prevalence of …
Future Market Insights delivers key insights on the global renal biomarker market in a new report titled “Renal Biomarker Market: Global Industry Analysis and Opportunity Assessment, 2016–2026.” In terms of revenue, the global renal biomarker market is projected to register a healthy CAGR of 7.0% over the forecast period. In this report, Future Market Insights throws light on the various factors and trends impacting market growth over the forecast period